TaiMed Biologics (Taiwan) Today
| 4147 Stock | TWD 84.80 2.00 2.42% |
Performance0 of 100
| Odds Of DistressLess than 20
|
TaiMed Biologics is selling for under 84.80 as of the 25th of April 2024; that is 2.42 percent increase since the beginning of the trading day. The stock's lowest day price was 83.3. TaiMed Biologics has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for TaiMed Biologics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2022 and ending today, the 25th of April 2024. Click here to learn more.
TaiMed Biologics Inc., a biotechnology company, develops health-care products. The company was founded in 2007 and is based in Taipei City, Taiwan. TAIMED BIOLOGICS operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. The company has 252.37 M outstanding shares. More on TaiMed Biologics
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
TaiMed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. TaiMed Biologics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding TaiMed Biologics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Nianyuan Zhang |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
TaiMed Biologics (4147) is traded on Taiwan OTC Exchange in Taiwan and employs 37 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate TaiMed Biologics's market, we take the total number of its shares issued and multiply it by TaiMed Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. TaiMed Biologics operates under Biotechnology sector and is part of Health Care industry. The entity has 252.37 M outstanding shares.
TaiMed Biologics has accumulated about 1.02 B in cash with (211.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.03.
Check TaiMed Biologics Probability Of Bankruptcy
Ownership AllocationTaiMed Biologics shows a total of 252.37 Million outstanding shares. TaiMed Biologics has 17.27 % of its outstanding shares held by insiders and 21.66 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check TaiMed Ownership Details
TaiMed Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of TaiMed Biologics jumping above the current price in 90 days from now is about 84.24%. The TaiMed Biologics probability density function shows the probability of TaiMed Biologics stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon TaiMed Biologics has a beta of -0.2818. This suggests as returns on the benchmark increase, returns on holding TaiMed Biologics are expected to decrease at a much lower rate. During a bear market, however, TaiMed Biologics is likely to outperform the market. Additionally, taiMed Biologics has an alpha of 0.014, implying that it can generate a 0.014 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of TaiMed Biologics to move above the current price in 90 days from now is about 84.24 (This TaiMed Biologics probability density function shows the probability of TaiMed Stock to fall within a particular range of prices over 90 days) .
TaiMed Biologics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. TaiMed Biologics market risk premium is the additional return an investor will receive from holding TaiMed Biologics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in TaiMed Biologics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although TaiMed Biologics' alpha and beta are two of the key measurements used to evaluate TaiMed Biologics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.09 | |||
| Semi Deviation | 2.69 | |||
| Standard Deviation | 2.87 | |||
| Variance | 8.25 |
TaiMed Stock Against Markets
Picking the right benchmark for TaiMed Biologics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in TaiMed Biologics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for TaiMed Biologics is critical whether you are bullish or bearish towards TaiMed Biologics at a given time. Please also check how TaiMed Biologics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in TaiMed Biologics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
TaiMed Biologics Corporate Directors
TaiMed Biologics corporate directors refer to members of a TaiMed Biologics board of directors. The board of directors generally takes responsibility for the TaiMed Biologics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of TaiMed Biologics' board members must vote for the resolution. The TaiMed Biologics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Mingjin Chen | Independent Director | Profile | |
| Luping Zhou | Director | Profile | |
| Zhongxian Liu | Director | Profile | |
| Zhaolian Huang | Director | Profile |
How to buy TaiMed Stock?
Before investing in TaiMed Biologics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in TaiMed Biologics. To buy TaiMed Biologics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of TaiMed Biologics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase TaiMed Biologics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located TaiMed Biologics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased TaiMed Biologics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as TaiMed Biologics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in TaiMed Biologics?
The danger of trading TaiMed Biologics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of TaiMed Biologics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than TaiMed Biologics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile TaiMed Biologics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in TaiMed Biologics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for TaiMed Stock analysis
When running TaiMed Biologics' price analysis, check to measure TaiMed Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TaiMed Biologics is operating at the current time. Most of TaiMed Biologics' value examination focuses on studying past and present price action to predict the probability of TaiMed Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TaiMed Biologics' price. Additionally, you may evaluate how the addition of TaiMed Biologics to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |